Stock screenerAll disclosures →
EDGAR →
BNTC
Conviction 73HealthcareScan · Thu, Jun 25, 2026Shooting star
BNTC$12.99-4.70%
ResistanceSupportVol 14Vol MA14 130.01K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price12.99
Change-4.70%
Gap-2.71%
Rel volume4.05×
Avg volume114.58K
Avg $ vol1.35M
SMA 2011.43
SMA 5011.89
SMA 20012.54
Price vs 50+9.27%
Price vs 200+3.57%
MA stackmixed
50/200 cross—
Supertrendup · 11.01
RSI (14)63
MACD hist0.30
MACD crossbull · 8d
Stoch %K / %D71 / 85
ADX (14)21
+DI / −DI32 / 10
RSI divergenceBullish
MACD divergenceBullish
ATR %+6.15%
ADR %6.33%
52w high16.52
52w low10.06
From 52w high-21.37%
Above 52w low+29.13%
New 52w highNo
SqueezeOff
Bollinger width31.83%
%B0.93
Donchian pos70.85%
Donchian high14.22
Donchian low10.00
AVWAP (52w high)12.22
vs AVWAP high+6.33%
AVWAP (52w low)11.59
vs AVWAP low+12.13%
OBV trendFlat
Chaikin MF (20)-0.04
Today vs 20d4.05×
Avg vol (14d)130.01K
Avg vol (20d)114.58K
Avg $ vol (20d)1.35M
Market cap446.26M
RS 3m (vs SPY)+15.13%
RS 6m (vs SPY)+10.79%
RS line new highNo
Trend template4/8
Technical rank64.5
1 week+10.08%
1 month+13.45%
3 months+19.83%
6 months+5.18%
1 year-13.23%
YTD+3.22%
P/E-11.77
P/B2.43
P/S—
P/FCF-18.90
EPS-1.05
Div yield—
ROE-20.68%
ROA-20.28%
Debt/Eq—
Current56.82
EV/EBITDA-6.27
Gross margin—
Net margin—
Rev growth-42.16%
EPS growth-74.32%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value261.5M
Revenue0
Net income-11.94M
Gross profit—
Free cash flow-23.61M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out34.35M
Employees19
ListedWed, Jul 11, 2012
Free float21.09M
Float %61.4%
Short interest2.33M
Days to cover30.8d
Short volume37.9%
Squeeze score62 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.24 vs −$0.27
Last surprise+11.1% beat
Setup gradeB
Conviction73 / 100
Pattern quality—
Tech rank64.5 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmShooting star
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in BNTC
No recent disclosed trades by Congress in BNTC. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BNTC · 1 buy
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Friedman David Matthew Director · Options (right to buy) · 2026-05-26 | Grant | 35K | $0 | 2026-05-26 | 2026-05-28 |
SEC filings
EDGAR filings in BNTC
No recent SEC filings on file for BNTC.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.